FDA Inspection 961189 — Rentschler Biopharma Inc.
The FDA completed an inspection of Rentschler Biopharma Inc. on February 23, 2016 in Milford, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 23, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Milford, MA (United States)